The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Nonalcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: A Meta-analysis
Open accessAbstract
OBJECTIVE: Several studies have explored the impact of nonalcoholic fatty liver disease (NAFLD) on risk of incident type 2 diabetes. However, the extent to which NAFLD may confer risk of incident diabetes remains uncertain. We performed a meta-analysis of relevant studies to quantify the magnitude of the association between NAFLD and risk of incident diabetes. RESEARCH DESIGN AND METHODS: We collected data using PubMed, Scopus, and Web of Science from January 2000 to July 2017. We included only large (n ≥500) observational studies with a follow-up duration of at least 1 year in which NAFLD was diagnosed on imaging methods. Eligible studies were selected according to predefined keywords and clinical outcomes. Data from selected studies were extracted, and meta-analysis was performed using random-effects modeling. RESULTS: A total of 19 observational studies with 296,439 individuals (30.1% with NAFLD) and nearly 16,000 cases of incident diabetes over a median of 5 years were included in the final analysis. Patients with NAFLD had a greater risk of incident diabetes than those without NAFLD (random-effects hazard ratio [HR] 2.22, 95% CI 1.84–2.60; I2 = 79.2%). Patients with more “severe” NAFLD were also more likely to develop incident diabetes; this risk increased across the ultrasonographic scores of steatosis (n = 3 studies), but it appeared to be even greater among NAFLD patients with advanced high NAFLD fibrosis score (n = 1 study; random-effects HR 4.74, 95% CI 3.54–5.94). Sensitivity analyses did not alter these findings. Funnel plot and Egger test did not reveal significant publication bias. Study limitations included high heterogeneity, varying degrees of confounder adjustment across individual studies, and lack of studies using liver biopsy. CONCLUSIONS: NAFLD is significantly associated with a twofold increased risk of incident diabetes. However, the observational design of the eligible studies does not allow for proving causality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781
EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.004 · Cited by 4,836
Byrne, C. D., & Targher, G. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.12.012 · Cited by 3,042
Self-citationMeta-analysis: Principles and procedures
Egger, M., Smith, G. D., & Phillips, A. N. (1997) · BMJ · doi:10.1136/bmj.315.7121.1533 · Cited by 2,415
Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
Anstee, Q. M., Targher, G., & Day, C. P. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.41 · Cited by 1,747
Self-citationNon-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis
Targher, G., Byrne, C. D., Lonardo, A., Zoppini, G., & Barbui, C. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.05.013 · Cited by 1,424
Self-citationMusso, G., Gambino, R., Cassader, M., & Pagano, G. (2011) · Annals of Medicine · doi:10.3109/07853890.2010.518623 · Cited by 1,293
Adams, L. A., Anstee, Q. M., Tilg, H., & Targher, G. (2017) · Gut · doi:10.1136/gutjnl-2017-313884 · Cited by 1,174
Self-citationTilg, H., Moschen, A. R., & Roden, M. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.147 · Cited by 1,002
Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance
Pal, D., Dasgupta, S., Kundu, R., Maitra, S., Das, G., Mukhopadhyay, S., Ray, S., Majumdar, S. S., & Bhattacharya, S. (2012) · Nature Medicine · doi:10.1038/nm.2851 · Cited by 922 · cited 1×
“Among the hepatokines, data about fetuin-Aaction inmiceand inhumans in particular supports a causative relationship of NAFLD with incident diabetes (38,41,42).”
BackgroundHepatocellular carcinoma in non-alcoholic fatty liver disease: An emerging menace
Baffy, G., Brunt, E. M., & Caldwell, S. H. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.10.027 · Cited by 858
Ballestri, S., Zona, S., Targher, G., Romagnoli, D., Baldelli, E., Nascimbeni, F., Roverato, A., Guaraldi, G., & Lonardo, A. (2016) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13264 · Cited by 717
Self-citationHepatokines: Linking nonalcoholic fatty liver disease and insulin resistance
Meex, R. C. R., & Watt, M. J. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.56 · Cited by 631
Causes, Characteristics, and Consequences of Metabolically Unhealthy Normal Weight in Humans
Stefan, N., Schick, F., & Häring, H.-U. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.07.008 · Cited by 575 · cited 1×
“This might also have important implications for future strategies in the prevention and treatment of type 2 diabetes and other cardiometabolic diseases in clinical practice (51,52).”
Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups
Lonardo, A., Bellentani, S., Argo, C. K., Ballestri, S., Byrne, C. D., Caldwell, S. H., Cortez-Pinto, H., Grieco, A., Machado, M. V., Miele, L., et al. (2015) · Digestive and Liver Disease · doi:10.1016/j.dld.2015.08.004 · Cited by 444
Self-citationNazare, J.-A., Smith, J. D., Borel, A.-L., Haffner, S. M., Balkau, B., Ross, R., Massien, C., Alméras, N., & Després, J.-P. (2012) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.035758 · Cited by 437
Non-invasive diagnosis of non-alcoholic fatty liver disease. A critical appraisal
Machado, M. V., & Cortez-Pinto, H. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2012.11.021 · Cited by 412
Benhamed, F., Denechaud, P.-D., Lemoine, M., Robichon, C., Moldes, M., Bertrand-Michel, J., Ratziu, V., Serfaty, L., Housset, C., Capeau, J., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci41636 · Cited by 408
Roles of diacylglycerols and ceramides in hepatic insulin resistance
Petersen, M. C., & Shulman, G. I. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.04.004 · Cited by 373
Ethnic differences in hepatic steatosis: An insulin resistance paradox?†
Guerrero, R., Vega, G. L., Grundy, S. M., & Browning, J. D. (2009) · Hepatology · doi:10.1002/hep.22726 · Cited by 368
Management of nonalcoholic fatty liver disease in patients with type 2 diabetes: a call to action
Bril, F., & Cusi, K. (2017) · Diabetes Care · doi:10.2337/dc16-1787 · Cited by 341
Moon, Y.-A., Liang, G., Xie, X., Frank-Kamenetsky, M., Fitzgerald, K., Koteliansky, V., Brown, M. S., Goldstein, J. L., & Horton, J. D. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2011.12.017 · Cited by 320
Furukawa, T. A., Guyatt, G. H., & Griffith, L. E. (2002) · International Journal of Epidemiology · doi:10.1093/ije/31.1.72 · Cited by 318
Kantartzis, K., Peter, A., Machicao, F., Machann, J., Wagner, S., Königsrainer, I., Königsrainer, A., Schick, F., Fritsche, A., Häring, H.-U., et al. (2009) · Diabetes · doi:10.2337/db09-0279 · Cited by 303
Nonalcoholic Fatty Liver Disease Is a Risk Factor for Type 2 Diabetes in Middle-Aged Japanese Men
Shibata, M., Kihara, Y., Taguchi, M., Tashiro, M., & Otsuki, M. (2007) · Diabetes Care · doi:10.2337/dc07-0792 · Cited by 238
Bi-directional analysis between fatty liver and cardiovascular disease risk factors
Ma, J., Hwang, S.-J., Pedley, A., Massaro, J. M., Hoffmann, U., Chung, R. T., Benjamin, E. J., Levy, D., Fox, C. S., & Long, M. T. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.09.022 · Cited by 234
Sung, K.-C., Jeong, W.-S., Wild, S. H., & Byrne, C. D. (2012) · Diabetes Care · doi:10.2337/dc11-1853 · Cited by 218
Self-citationPhenotypes of prediabetes and stratification of cardiometabolic risk
Stefan, N., Fritsche, A., Schick, F., & Häring, H.-U. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)00082-6 · Cited by 208
Yamazaki, H., Tsuboya, T., Tsuji, K., Dohke, M., & Maguchi, H. (2015) · Diabetes Care · doi:10.2337/dc15-0140 · Cited by 172
Resolution of Fatty Liver and Risk of Incident Diabetes
Sung, K.-C., Wild, S. H., & Byrne, C. D. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1519 · Cited by 169
Self-citationMinehira, K., Young, S. G., Villanueva, C. J., Yetukuri, L., Oresic, M., Hellerstein, M. K., Farese, R. V., Horton, J. D., Preitner, F., Thorens, B., et al. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800248-jlr200 · Cited by 164
Chang, Y., Jung, H.-S., Yun, K. E., Cho, J., Cho, Y. K., & Ryu, S. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.349 · Cited by 163
Circulating fetuin-A and free fatty acids interact to predict insulin resistance in humans
Stefan, N., & Häring, H.-U. (2013) · Nature Medicine · doi:10.1038/nm.3116 · Cited by 160
Park, S. K., Seo, M. H., Shin, H. C., & Ryoo, J.-H. (2013) · Hepatology · doi:10.1002/hep.26183 · Cited by 158
Fukuda, T., Hamaguchi, M., Kojima, T., Hashimoto, Y., Ohbora, A., Kato, T., Nakamura, N., & Fukui, M. (2015) · Liver International · doi:10.1111/liv.12912 · Cited by 157
Chen, S. C.-C., Tsai, S. P., Jhao, J.-Y., Jiang, W.-K., Tsao, C. K., & Chang, L.-Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-04631-7 · Cited by 148
Bae, J. C., Rhee, E., Lee, W., Park, S. E., Park, C., Oh, K. W., Park, S. W., & Kim, S. W. (2011) · Diabetes Care · doi:10.2337/dc10-1991 · Cited by 141
Interethnic Differences in Muscle, Liver and Abdominal Fat Partitioning in Obese Adolescents
Líška, D., Dufour, S., Zern, T. L., Taksali, S. E., Cali, A. M. G., Dziura, J. D., Shulman, G. I., Pierpont, B. M., & Caprio, S. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000569 · Cited by 137
Influence of non‐alcoholic fatty liver disease on the development of diabetes mellitus
Kasturiratne, A., Weerasinghe, S., Dassanayake, A. S., Rajindrajith, S., Silva, A. P. D., Kato, N., Wickremasinghe, A. R., & de Silva, H. J. (2012) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2012.07264.x · Cited by 114
Fatty liver is an independent risk factor for the development of Type 2 diabetes in Korean adults
Kim, C., Park, J.-Y., Lee, K.-U., Kim, J. H., & Kim, H. ‐. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02410.x · Cited by 112
Targher, G., Marchesini, G., & Byrne, C. D. (2016) · Diabetes & Metabolism · doi:10.1016/j.diabet.2016.04.002 · Cited by 91
Self-citationType 2 diabetes and risk of hospital admission or death for chronic liver diseases
Wild, S. H., Morling, J. R., McAllister, D., Kerssens, J., Fischbacher, C., Parkes, J., Roderick, P. J., Sattar, N. A., & Byrne, C. D. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.01.014 · Cited by 84
Self-citationLi, Y., Wang, J., Tang, Y., Han, X., Liu, B., Hu, H., Li, X., Yang, K., Yuan, J., Miao, X., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174291 · Cited by 74
Björkström, K., Stal, P. I., Hultcrantz, R. W., & Hagström, H. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2017.04.040 · Cited by 61
Choi, J. H., Rhee, E., Bae, J. C., Park, S. E., Park, C., Cho, Y. K., Oh, K. W., Park, S., & Lee, W. (2013) · Archives of Medical Research · doi:10.1016/j.arcmed.2013.01.007 · Cited by 59
Li, W. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i32.9607 · Cited by 50
Liu, M., Wang, J., Zeng, J., Cao, X., & He, Y. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-3440 · Cited by 50
The Association of Fatty Liver and Diabetes Risk.
Okamoto, M., Takeda, Y., Yoda, Y., Kobayashi, K., Fujino, M., & Yamagata, Z. (2003) · Journal of Epidemiology · doi:10.2188/jea.13.15 · Cited by 49
Liver fat, statin use, and incident diabetes: The Multi-Ethnic Study of Atherosclerosis
Shah, R. V., Allison, M., Lima, J. A. C., Bluemke, D. A., Abbasi, S. A., Ouyang, P., Jerosch‐Herold, M., Ding, J., Budoff, M. J., & Murthy, V. L. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.07.018 · Cited by 46
Ming, J., Xu, S., Gao, B., Liu, G., Ji, Y., Yang, F., Jia, Y., Fang, Y., & Ji, Q. (2015) · Liver International · doi:10.1111/liv.12851 · Cited by 44
Chen, G., Cao, H., Li, F., Cai, X., Ao, Q., Gao, Y. T., & Fan, J. (2015) · Journal of Diabetes Investigation · doi:10.1111/jdi.12395 · Cited by 22
Cited by
Rinella, M. E., Neuschwander-Tetri, B. A., Siddiqui, M. S., Abdelmalek, M. F., Caldwell, S., Barb, D., Kleiner, D. E., & Loomba, R. (2023) · Hepatology · doi:10.1097/hep.0000000000000323 · Cited by 2,667
Cusi, K., Isaacs, S., Barb, D., Basu, R., Caprio, S., Garvey, W. T., Kashyap, S., Mechanick, J. I., Mouzaki, M., Nadolsky, K., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.03.010 · Cited by 1,021
Ye, Q., Zou, B., Yeo, Y. H., Li, J., Huang, D. Q., Wu, Y., Yang, H., Liu, C., Kam, L. Y., Tan, X. X. E., et al. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(20)30077-7 · Cited by 925
Kuchay, M. S., Krishan, S., Mishra, S. K., Farooqui, K. J., Singh, M. K., Wasir, J. S., Bansal, B., Kaur, P., Jevalikar, G., Gill, H. K., et al. (2018) · Diabetes Care · doi:10.2337/dc18-0165 · Cited by 662
Mantovani, A., Petracca, G., Beatrice, G., Tilg, H., Byrne, C. D., & Targher, G. (2021) · Gut · doi:10.1136/gutjnl-2020-322572 · Cited by 481
Self-citation
Metadata
- Authors
- Mantovani, A., Byrne, C. D., Bonora, E., & Targher, G.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2018-01-12
- Volume
- 41
- Issue
- 2
- Pages
- 372-382
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2791409258
- Cited by
- 624
- References
- 53
- FWCI
- 12.20
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.